Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the company presentation session at BIO 2018.
  • Written by Admin
  • Written date 2019-01-14 11:36:01
  • Inquire 1620

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is invited to present at the company presentation session at BIO 2018(http://convention.bio.org/2018/). 


Company Name: PharmAbcine

Presentation Date: Tuesday, June 5th

 

Presentation Time: 11:15:00 AM

 

Presentation Room: Theater 1

 

Speaker: Jin-San Yoo

 

 

For investors attending the BIO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management 

at sungwoo.kim@pharmabcine.com.

List





Prev PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Gliob...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...